Iron Overload What Is the Role of Public Health?

被引:5
作者
Hulihan, Mary M. [1 ]
Sayers, Cindy A. [1 ]
Grosse, Scott D. [1 ]
Garrison, Cheryl [2 ]
Grant, Althea M. [1 ]
机构
[1] CDC, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA
[2] Iron Disorders Inst, Greenville, SC USA
关键词
AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; PERIPHERAL ARTERIAL-DISEASE; HEREDITARY HEMOCHROMATOSIS; JUVENILE HEMOCHROMATOSIS; C282Y HOMOZYGOTES; HFE GENE; POPULATION; MUTATION; FERRITIN; MORBIDITY;
D O I
10.1016/j.amepre.2011.09.020
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Hereditary hemochromatosis type 1, also known as hereditary hemochromatosis classical (HHC), is an iron overload disorder associated, in most cases, with mutations of the hemochromatosis (HFE) gene. Although suggested algorithms for diagnosing iron overload are available, there are still questions about options for genetic and biochemical screening for hemochromatosis and duration of treatment. This article provides a summary of an expert workgroup meeting convened on September 24-25, 2009, entitled "Iron Overload: What is the Role of Public Health?" The purpose of the meeting was to enable subject matter experts to share their most recent clinical and scientific iron overload information and to facilitate the discussion of future endeavors, with special emphasis on the role of public health in this field. The two main topics were the research priorities of the field, including clinical, genetic, and public health issues, and the concerns about the validity of current screening recommendations for the condition. (Am J Prev Med 2011;41(6S4):S422-S427) Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine
引用
收藏
页码:S422 / S427
页数:6
相关论文
共 42 条
  • [1] A genome-wide linkage scan for iron phenotype quantitative trait loci: the HEIRS Family Study
    Acton, R. T.
    Snively, B. M.
    Barton, J. C.
    McLaren, C. E.
    Adams, P. C.
    Rich, S. S.
    Eckfeldt, J. H.
    Press, R. D.
    Sholinsky, P.
    Leiendecker-Foster, C.
    McLaren, G. D.
    Speechley, M. R.
    Harris, E. L.
    Dawkins, F. W.
    Gordeuk, V. R.
    [J]. CLINICAL GENETICS, 2007, 71 (06) : 518 - 529
  • [2] Hemochromatosis and iron-overload screening in a racially diverse population
    Adams, PC
    Reboussin, DM
    Barton, JC
    McLaren, CE
    Eckfeldt, JH
    McLaren, GD
    Dawkins, FW
    Acton, RT
    Harris, EL
    Gordeuk, VR
    Leiendecker-Foster, C
    Speechley, M
    Snively, BM
    Holup, JL
    Thomson, E
    Sholinsky, P
    Acton, RT
    Barton, JC
    Dixon, D
    Rivers, CA
    Tucker, D
    Ware, JC
    McLaren, CE
    McLaren, GD
    Anton-Culver, H
    Baca, JA
    Bent, TC
    Brunner, LC
    Dao, MM
    Jorgensen, KS
    Kuniyoshi, J
    Le, HD
    Masatsugu, MK
    Meyskens, FL
    Morohashi, D
    Nguyen, HP
    Panagon, SN
    Phung, C
    Raymundo, V
    Ton, T
    Walker, AP
    Wenzel, LB
    Ziogas, A
    Adams, PC
    Bloch, E
    Chakrabarti, S
    Fleischhauer, A
    Harrison, H
    Jia, K
    Larson, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) : 1769 - 1778
  • [3] Iron-overload-related disease in HFE hereditary hemochromatosis
    Allen, Katrina J.
    Gurrin, Lyle C.
    Constantine, Clare C.
    Osborne, Nicholas J.
    Delatycki, Martin B.
    Nicoll, Amanda J.
    McLaren, Christine E.
    Bahlo, Melanie
    Nisselle, Amy E.
    Vulpe, Chris D.
    Anderson, Gregory J.
    Southey, Melissa C.
    Giles, Graham G.
    English, Dallas R.
    Hopper, John L.
    Olynyk, John K.
    Powell, Lawrie W.
    Gertig, Dorota M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (03) : 221 - 230
  • [4] Chelation therapy for iron overload
    Barton J.C.
    [J]. Current Gastroenterology Reports, 2007, 9 (1) : 74 - 82
  • [5] HAMP promoter mutation nc.-153C>T in 785 HEIRS Study participants
    Barton, James C.
    Letendecker-Foster, Catherine
    Li, Honggui
    DelRio-LaFrentere, Susie
    Acton, Ronald T.
    Eckfeldt, John H.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (10): : 1465 - 1465
  • [6] Management of hemochromatosis
    Barton, JC
    McDonnell, SM
    Adams, PC
    Brissot, P
    Powell, LW
    Edwards, CQ
    Cook, JD
    Kowdley, KV
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) : 932 - 939
  • [7] Common variants in TMPRSS6 are associated with iron status and erythrocyte volume
    Benyamin, Beben
    Ferreira, Manuel A. R.
    Willemsen, Gonneke
    Gordon, Scott
    Middelberg, Rita P. S.
    McEvoy, Brian P.
    Hottenga, Jouke-Jan
    Henders, Anjali K.
    Campbell, Megan J.
    Wallace, Leanne
    Frazer, Ian H.
    Heath, Andrew C.
    de Geus, Eco J. C.
    Nyholt, Dale R.
    Visscher, Peter M.
    Penninx, Brenda W.
    Boomsma, Dorret I.
    Martin, Nicholas G.
    Montgomery, Grant W.
    Whitfield, John B.
    [J]. NATURE GENETICS, 2009, 41 (11) : 1173 - 1175
  • [8] BILLINGS PR, 1993, NEW ENGL J MED, V329, P2037
  • [9] The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
    Camaschella, C
    Roetto, A
    Cali, A
    De Gobbi, M
    Garozzo, G
    Carella, M
    Majorano, N
    Totaro, A
    Gasparini, P
    [J]. NATURE GENETICS, 2000, 25 (01) : 14 - 15
  • [10] Hereditary Hemochromatosis Is Characterized by a Clinically Definable Arthropathy That Correlates With Iron Load
    Carroll, G. J.
    Breidahl, W. H.
    Bulsara, M. K.
    Olynyk, J. K.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (01): : 286 - 294